Published in Arch Ophthalmol on July 01, 2001
Ocular melanoma: an overview of the current status. Int J Clin Exp Pathol (2013) 1.43
Cyclooxygenase-2 expression in human irradiated uveal melanomas. Int Ophthalmol (2007) 1.40
Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial. Trials (2014) 1.39
Reduced expression of autotaxin predicts survival in uveal melanoma. Br J Ophthalmol (2007) 1.10
Laser photocoagulation for radiation retinopathy after ophthalmic plaque radiation therapy. Br J Ophthalmol (2005) 1.04
The evolving role of radiation therapy in the management of malignant melanoma. Int J Radiat Oncol Biol Phys (2011) 1.04
Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc (2002) 1.01
Uveal melanoma. J Skin Cancer (2011) 0.98
Choroidal melanoma. Oman J Ophthalmol (2012) 0.97
Manganese-enhanced MRI of human choroidal melanoma xenografts. Invest Ophthalmol Vis Sci (2007) 0.92
Rare presentations of primary melanoma and special populations: a systematic review. Am J Clin Oncol (2014) 0.92
The pathology of ocular cancer. Eye (Lond) (2012) 0.91
The clinical case for proton beam therapy. Radiat Oncol (2012) 0.90
Post-brachytherapy initial tumour regression rate correlates with metastatic spread in posterior uveal melanoma. Br J Ophthalmol (2004) 0.89
Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity. Clin Ophthalmol (2012) 0.88
Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents. Onco Targets Ther (2011) 0.88
Transcriptional profiling of human uveal melanoma from cell lines to intraocular tumors to metastasis. Clin Exp Metastasis (2007) 0.87
The Zimmerman-McLean-Foster hypothesis: 25 years later. Br J Ophthalmol (2004) 0.87
Fifteen years of work: the COMS outcomes for medium-sized choroidal melanoma. Arch Ophthalmol (2001) 0.85
Quality of life in patients with malignant choroidal melanoma after radiotherapy. Graefes Arch Clin Exp Ophthalmol (2003) 0.84
Eccentric ruthenium plaque radiotherapy of posterior choroidal melanoma. Graefes Arch Clin Exp Ophthalmol (2012) 0.83
Transscleral local resection versus iodine brachytherapy for uveal melanomas that are large because of tumour height. Graefes Arch Clin Exp Ophthalmol (2006) 0.82
Bevacizumab and intraocular tumors: an intriguing paradox. Mol Vis (2012) 0.82
Ruthenium-106 brachytherapy for thick uveal melanoma: reappraisal of apex and base dose radiation and dose rate. J Contemp Brachytherapy (2016) 0.81
Long-term survivors with metastatic uveal melanoma. Open Ophthalmol J (2012) 0.81
Modeling human choroidal melanoma xenograft growth in immunocompromised rodents to assess treatment efficacy. Invest Ophthalmol Vis Sci (2012) 0.81
Uveal melanoma in the Saudi Arabian population: Two decades of management at the King Khaled Eye Specialist Hospital. Saudi J Ophthalmol (2009) 0.81
Episcleral plaque brachytherapy using 'BARC I-125 Ocu-Prosta seeds' in the treatment of intraocular tumors: a single-institution experience in India. Indian J Ophthalmol (2012) 0.80
Measurement of human choroidal melanoma xenograft volume in rats using high-frequency ultrasound. Invest Ophthalmol Vis Sci (2008) 0.80
18 years' experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma. Br J Ophthalmol (2005) 0.79
Small choroidal melanoma with massive extraocular extension: invasion through posterior scleral emissary channels. Int Ophthalmol (2001) 0.79
Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment. Clin Ophthalmol (2013) 0.78
Outcomes and control rates for I-125 plaque brachytherapy for uveal melanoma: a community-based institutional experience. ISRN Ophthalmol (2014) 0.78
Dosimetry and treatment planning of Occu-Prosta I-125 seeds for intraocular lesions. J Med Phys (2008) 0.78
Correlation of histological findings from a large ciliochoroidal melanoma with CT perfusion and 3T MRI dynamic enhancement studies. Clin Ophthalmol (2008) 0.77
Metastasis rates and sites after treatment for choroidal melanoma by proton beam irradiation or by enucleation. Clin Ophthalmol (2008) 0.77
Long-term visual acuity outcomes in patients with uveal melanoma treated with (125)I episcleral OSU-Nag plaque brachytherapy. Brachytherapy (2016) 0.77
Management of uveal melanoma: a consensus-based provincial clinical practice guideline. Curr Oncol (2016) 0.76
Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition). Ann Transl Med (2015) 0.76
Modulation of radiation injury response in retinal endothelial cells by quinic acid derivative KZ-41 involves p38 MAPK. PLoS One (2014) 0.76
The effects of a cyclooxygenase-2 (COX-2) expression and inhibition on human uveal melanoma cell proliferation and macrophage nitric oxide production. J Carcinog (2007) 0.76
The use of imbricated sutures in radioactive plaque brachytherapy surgery. Clin Ophthalmol (2010) 0.75
Concomitant primary breast carcinoma and primary choroidal melanoma: a case report. J Med Case Rep (2008) 0.75
Identification of novel chemotherapeutic strategies for metastatic uveal melanoma. Sci Rep (2017) 0.75
Visual Acuity, Contrast Sensitivity and Color Vision Three Years After Iodine-125 Brachytherapy for Choroidal and Ciliary Body Melanoma. Open Ophthalmol J (2015) 0.75
Ocular melanoma-when you have seen one, you have not seen them all: a clinical outcome study from the Surveillance, Epidemiology and End Results (SEER) database (1973-2012). Clin Ophthalmol (2017) 0.75
Ocular tumors: Triumphs, challenges and controversies. Saudi J Ophthalmol (2013) 0.75
EPIDEMIOLOGICAL ANALYSIS OF OCULAR MELANOMA IN UNIVERSITY CLINIC CENTER IN TUZLA, BOSNIA AND HERZEGOVINA. Mater Sociomed (2016) 0.75
On the feasibility of polyurethane based 3D dosimeters with optical CT for dosimetric verification of low energy photon brachytherapy seeds. Med Phys (2014) 0.75
Options for management of intra ocular tumors. Indian J Ophthalmol (2015) 0.75
Uveal Melanoma: Current Trends in Diagnosis and Management. Turk J Ophthalmol (2016) 0.75
Atypical Presentation: Metastatic Uveal Melanoma in a Young Patient without Visual Complaints. Front Oncol (2017) 0.75
23-mm iodine-125 plaque for uveal melanoma: benefit of vitrectomy and silicone oil on visual acuity. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
Gamma knife radiosurgery for the treatment of uveal melanoma and uveal metastases. Int J Retina Vitreous (2017) 0.75
Experiences of two different modalities in the management of choroidal melanoma in the Asian Indian population. South Asian J Cancer (2017) 0.75
Radiotherapy in ophthalmology : 2004 Jules Gonin lecture of the Retina Research Foundation. Graefes Arch Clin Exp Ophthalmol (2006) 0.75
Quality of life in the follow-up of uveal melanoma patients after enucleation in comparison to CyberKnife treatment. Graefes Arch Clin Exp Ophthalmol (2015) 0.75
Ruthenium-106 plaque radiotherapy alone or in combination with transpupillary thermotherapy in the management of choroidal melanoma. Jpn J Ophthalmol (2010) 0.75
Juxtapapillary and circumpapillary choroidal melanoma: globe-sparing treatment outcomes with iodine-125 notched plaque brachytherapy. Graefes Arch Clin Exp Ophthalmol (2017) 0.75
The VF-14. An index of functional impairment in patients with cataract. Arch Ophthalmol (1994) 6.00
Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation. N Engl J Med (1999) 5.27
A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology (2001) 5.16
Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol (1984) 4.68
Ascertainment corrected rates: applications of capture-recapture methods. Int J Epidemiol (1993) 4.36
Age-related macular degeneration. Surv Ophthalmol (1988) 4.18
Incident Chlamydia trachomatis infections among inner-city adolescent females. JAMA (1998) 4.12
Risk factors for open-angle glaucoma. The Barbados Eye Study. Arch Ophthalmol (1995) 4.09
The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol (1994) 3.92
Senile macular degeneration: a case-control study. Am J Epidemiol (1983) 3.04
Foveolar choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci (1998) 3.01
Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group. Arch Ophthalmol (1990) 2.78
Myelinated retinal nerve fibers. Am J Ophthalmol (1981) 2.45
Long-term follow-up of central serous chorioretinopathy. Br J Ophthalmol (1984) 2.40
Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial. Ann Intern Med (1991) 2.37
A histopathologic study of Best's macular dystrophy. Arch Ophthalmol (1982) 2.27
Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina (1996) 2.27
Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol (2000) 2.19
Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol (1989) 2.16
Screening for diabetic retinopathy. Ann Intern Med (1992) 2.12
National study of cataract surgery outcomes. Variation in 4-month postoperative outcomes as reflected in multiple outcome measures. Ophthalmology (1994) 2.09
Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16. Ophthalmology (2001) 2.09
Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol (2005) 2.05
Natural course of choroidal neovascular membranes within the foveal avascular zone in senile macular degeneration. Am J Ophthalmol (1982) 1.97
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol (2006) 1.93
A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol (1992) 1.75
Bardet-Biedl syndrome and related disorders. Arch Ophthalmol (1982) 1.74
Reproducibility and responsiveness of the VF-14. An index of functional impairment in patients with cataracts. Arch Ophthalmol (1995) 1.74
Prognosis of patients with bilateral macular drusen. Ophthalmology (1984) 1.73
Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina (1994) 1.72
Psychophysical evidence for rod vulnerability in age-related macular degeneration. Invest Ophthalmol Vis Sci (2000) 1.67
Variation in cataract surgery practice and clinical outcomes. Ophthalmology (1994) 1.67
International ophthalmology strategic plan to preserve and restore vision-vision for the future. Am J Ophthalmol (2001) 1.65
Combined hamartomas of the retina and retinal pigment epithelium. Ophthalmology (1984) 1.63
Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg (2001) 1.63
Posterior vitreous cyst. Am J Ophthalmol (1990) 1.62
Laser-induced drusen reduction improves visual function at 1 year. Choroidal Neovascularization Prevention Trial Research Group. Ophthalmology (1999) 1.61
Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol (1998) 1.58
Severe retinal vaso-occlusive disease in systemic lupus erythematous. Arch Ophthalmol (1986) 1.56
Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol (1997) 1.55
Macular scatter ('grid') laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial. Arch Ophthalmol (1996) 1.55
Frequency of adverse systemic reactions after fluorescein angiography. Results of a prospective study. Ophthalmology (1991) 1.54
The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol (1989) 1.53
Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy? Int J Radiat Oncol Biol Phys (1995) 1.51
Purtscher's-like retinopathy after childbirth. Ophthalmology (1990) 1.50
Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurology (2011) 1.49
Ten-year outcomes for pathologic node-positive patients treated in RTOG 75-06. Int J Radiat Oncol Biol Phys (1998) 1.49
Pathologic myopia and choroidal neovascularization. Am J Ophthalmol (1981) 1.49
Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity. Ophthalmology (1997) 1.48
Evaluation of a xylene substitute in Ehrlich indole test. J Clin Microbiol (1986) 1.48
Radiation therapy for glottic cancer using 6-MV photons. Cancer (1996) 1.48
Diabetes mellitus and intraocular lens implantation. Ophthalmology (1983) 1.47
Leukemic retinopathy. Relationship between fundus lesions and hematologic parameters at diagnosis. Ophthalmology (1989) 1.46
Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol (2000) 1.46
Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology (1987) 1.46
Choroidal neovascularization as a late complication of ocular toxoplasmosis. Am J Ophthalmol (1981) 1.46
No one knows the preferred management for choroidal melanoma. Am J Ophthalmol (1996) 1.44
Multivariate analysis of factors associated with unplanned admission in 'outpatient' ophthalmic surgery. Ophthalmic Surg (1988) 1.44
Massive hemorrhage complicating age-related macular degeneration. Clinicopathologic correlation and role of anticoagulants. Ophthalmology (1986) 1.44
Association of higher diastolic blood pressure levels with cognitive impairment. Neurology (2009) 1.43
Histopathologic features of idiopathic macular holes and cysts. Ophthalmology (1990) 1.43
Risk factors for childhood burns: a case-control study of Ghanaian children. J Epidemiol Community Health (1995) 1.42
Impact of radiation dose and tumor size on large cell lymphoma patients in complete response after integrated CHOP-Bleo-radiation treatment protocol. Int J Radiat Oncol Biol Phys (1995) 1.40
Long-term follow-up of radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2004) 1.40
Radiation therapy for squamous cell carcinoma of the tonsil. Mayo Clin Proc (1994) 1.39
Visual abnormalities associated with high-energy microwave exposure. Retina (1993) 1.38
Linear accelerator sypervoltage radiation therapy: testicular tumors. Radiology (1968) 1.38
Central serous chorioretinopathy and pregnancy. Arch Ophthalmol (1993) 1.37
Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 1.36
Subfoveal choroidal neovascular membranes in age-related macular degeneration. Visual prognosis in eyes with relatively good initial visual acuity. Arch Ophthalmol (1986) 1.35
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled. COMS Report No. 17. Arch Ophthalmol (2001) 1.34
Long-term evaluation of patients with Best's vitelliform dystrophy. Ophthalmology (1981) 1.33
Clinical features of idiopathic macular cysts and holes. Am J Ophthalmol (1982) 1.33
Natural course of poorly defined choroidal neovascularization associated with macular degeneration. Arch Ophthalmol (1988) 1.31
Follow-up study of detachment of the retinal pigment epithelium. Br J Ophthalmol (1980) 1.30
The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24. Am J Ophthalmol (2004) 1.29
Distribution of intraocular pressure. The Barbados Eye Study. Arch Ophthalmol (1997) 1.28
Differential diagnosis between radiation and tumor plexopathy of the pelvis. Neurology (1985) 1.28
Contrast sensitivity in age-related macular degeneration. Arch Ophthalmol (1988) 1.28
Clinicopathologic findings in a patient with serpiginous choroiditis and treated choroidal neovascularization. Retina (1989) 1.27